Fingerprint
Dive into the research topics of 'Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNA'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically